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Mucosal epithelial cells, including those at the ocular surface, resist infection by most microbes in vivo but
can be susceptible to microbial virulence in vitro. While fluids bathing mucosal surfaces (e.g. tears) contain
antimicrobials, potentially pathogenic microbes often thrive in these fluids, suggesting that additional
mechanisms mediate epithelial resistance in vivo. Here, tear fluid acted directly upon epithelial cells to
enhance their resistance to bacterial invasion and cytotoxicity. Resistance correlated with tear
fluid-magnified activation of NFkB and AP-1 transcription factors in epithelial cells in response to bacterial
antigens, suggesting priming of innate defense pathways. Further analysis revealed differential regulation of
potential epithelial cell defense genes by tears. siRNA knockdown confirmed involvement of at least two
factors, RNase7 and ST-2, for which tears increased mRNA levels, in protection against bacterial invasion.
Thus, the role of mucosal fluids in defense can include modulation of epithelial immunity, in addition to
direct effects on microbes.
P seudomonas aeruginosa is a Gram-negative opportunistic bacterium that does not normally infect healthyepithelial-lined tissue surfaces in vivo1. However, epithelial cells derived from these tissues become exqui-sitely sensitive to a variety of virulence mechanisms of P. aeruginosa and other opportunistic pathogens if
grown in cell culture media in vitro2, 3. One difference between the in vivo environment and standard in vitro cell
culture conditions for mucosal epithelia is the presence versus absence of mucosal fluid. Indeed, it is commonly
assumed that bacteriostatic or bactericidal activities of molecular factors in mucosal fluids protect against
infection in vivo. Supporting a role for mucosal fluids in defense, we have previously shown that human tear
fluid can protect corneal epithelial cells against P. aeruginosa invasion of, and cytotoxicity towards, corneal
epithelial cells in vitro, and against virulence in vivo, if added with the bacterial inoculum4, 5. However, in the
same study we reported that human tear fluid removed from the eye does not consistently inhibit the growth of
P. aeruginosa strains that it protects cells against. This result suggested mechanisms independent of direct
antimicrobial activity were involved in the epithelial protective effects of tear fluid. The same is likely to be true
of other mucosal fluids, many of which are known to support survival of a rich and often complex microbiota6–8.
Here, we used P. aeruginosa, tear fluid and corneal epithelial cells to test the hypothesis that mucosal fluid can act
directly upon epithelial cells to enhance their resistance to invasion and cytotoxic virulence mechanisms of bacteria.
Results
Exposure to cells did not enhance bacteriostatic activity of tear fluid. Epithelial cell induced activation of tear
fluid bacteriostatic activity would provide a different explanation for why incubation of cells with tear fluid
protects the cells from P. aeruginosa. To explore this alternate hypothesis, bacteriostatic activity of human tears
pre-exposed to cultured corneal epithelial cells overnight was compared to tear fluid that had not been pre-
exposed to cultured cells in vitro. Results showed that three of the four P. aeruginosa strains tested could grow in
human tear fluid whether or not the tears were pre-exposed to human corneal epithelial cells in vitro, with no
significant increase in bacteriostatic activity noted after the tears had been exposed to cells (Fig. 1a).
Pre-exposing epithelial cells to human tear fluid increased cellular resistance to bacterial-induced invasion or
cytotoxicity.We next explored the impact of human tear fluid on cellular susceptibility to P. aeruginosa invasion
or cytotoxic virulence mechanisms. Cells pre-exposed to human tear fluid for 16 h were compared to cells pre-
exposed only to media (controls) for their susceptibility to P. aeruginosa invasion and cytotoxic activity,
respectively. Before adding the bacterial inoculum, tear fluid was removed by washing cells with phosphate
buffered saline. After washing, cells were challenged with 104 cfu P. aeruginosa for 3 h. Cells pre-exposed to
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tear fluid had significantly reduced susceptibility to invasion by all of
three bacterial strains tested, with 2.5-, 5- and 3.5-fold reductions
compared to controls observed for P. aeruginosa strains 19660, 6294
and PAO1, respectively (Fig. 1b). Tear pre-exposure also increased
cellular resistance to killing by the cytotoxic P. aeruginosa strain 6206
(, 3 fold) (Fig. 1c, d).
Tear fluid magnified bacterial-induced activation of NFkB and
AP-1 transcription factors. The above data suggested that the
mechanism(s) by which tear fluid protects against P. aeruginosa
invasion and cytotoxicity involves modulation of corneal epithelial
cell defenses. Thus, we used a 10-pathway Reporter Assay, which
utilizes a transcription factor-responsive firefly luciferase construct
and a constitutively-expressing Renilla luciferase construct, to
determine the impact of tear fluid on transcription factor
activation in corneal epithelial cells in response to bacterial
challenge. Corneal epithelial cells were incubated with either tears
or media for 16 h, washed, then incubated for 3 h with P. aeruginosa
supernatant containing surface antigens (LPS, flagellin and pilin)9.
Results showed that tear fluid pre-exposure magnified bacterial
antigen-induced increases in luciferase expression controlled by
NFkB and AP-1 transcription factors by ,5- and 20-fold,
respectively (Fig. 2a).
Impact of tear fluid on expression of specific known epithelial-
expressed antimicrobial factors. Increased resistance to bacterial
invasion and cytotoxicity accompanied by priming of two known
innate defense signaling pathways, suggested that inducible
antimicrobial factors in corneal epithelial cells might be
upregulated by tear fluid. We began by exploring such factors
already known to be expressed by these cells that have been shown
to be inducible9–12. Thus, mRNA for hBD-2, hBD-3 and LL-37 was
examined after exposure to either media or tear fluid (Fig. 2b), with
or without subsequent inoculation with P. aeruginosa antigens
(Fig. 2c). Only hBD-3 mRNA expression was increased by tear
fluid, and by only ,1.5 fold (Fig. 2b).
Since our unpublished results showed cell lysate fractions contain-
ing factors, 3 kDa had antimicrobial activity against P. aeruginosa
(data not shown), we next focused onmolecules of that size known to
be expressed by other epithelial cell types to explore if tear fluid
induced their expression. Histatin 3, a precursor to histatin 5 and
P113, was found expressed in significant quantities by the corneal
epithelial cells, but only after tear pre-exposure (Fig. 2b). Bacterial
exposure further enhanced the expression of histatin 3 in cells that
had been pre-exposed to tear fluid. Histatin 5, derived by proteolytic
cleavage of histatin 3, has potent antimicrobial activity and is
produced by parotid and submandibular salivary glands13, 14. P113
Figure 1 | Pre-exposing Epithelial Cells to Human Tear Fluid Protects against P. aeruginosa Invasion and Cytotoxicity, without affecting Tear
Bacteriostatic Activity. a, P. aeruginosa (,104 cfu) were suspended in cell culture media, tears, or tears pre-exposed to corneal epithelial cells for 3 h at
37 uC. Tear bacteriostatic activity was unaffected by prior exposure to epithelia. b, c, d,. Pre-exposure to tear fluid protected corneal epithelial cells against
P. aeruginosa invasion (b) and cytotoxicity (strain 6206) measured by trypan blue staining of dead/dying cells (c, d). Epithelial cells were exposed to tear
fluid or cell culture media for 16 h then inoculated with P. aeruginosa (,104 cfu in cell culture media, 3 h at 37uC, see methods).
www.nature.com/scientificreports
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(, 1.5 kDa), a cleaved product of its parent molecule, histatin 5, also
has potent antibacterial activity against P. aeruginosa15.
Microarray analysis of tear fluid effects. To determine if there
might be other critical defense genes differentially regulated by tear
fluid, we performed full human genome microarray analysis of cells
pre-exposed to tear fluid, with and without subsequent exposure to
bacterial antigens.With exposure to tear fluid only, 192 and 29 probe
sets were up- and down-regulated, respectively by at least 4 fold or
more (Fig. 3a). Pre-exposure to tear fluid for cells that were then
exposed to P. aeruginosa antigens (compared to P. aeruginosa
antigen challenge without tear pre-exposure) up- and down-
regulated 151 and 160 probe sets, respectively by at least 4 fold or
more (Fig. 3b). Two genes, RNase7 and ST2 were highly upregulated
by multiple probe sets in both sets of experiments; tear fluid
upregulated RNase7 by 28–40 fold and ST2 by 18–198 fold, and
cells exposed to P. aeruginosa antigens with pre-exposure to tears
upregulated RNase7 by 24–47 fold and ST2 by 33–171 fold. Semi-
quantitative RT-PCR confirmed upregulation of these factors
(Fig. 4a, b, c).
siRNA knockdown studies. Since RNase7 and ST2 have both been
shown to play protective roles in immunity, andmRNA levels of each
were significantly increased by tear fluid pre-exposure, which also
protected cells against P. aeruginosa, the impact of siRNA
knockdown of these molecules on epithelial cell resistance to
P. aeruginosa was explored. Knockdown of either RNase7 or ST2,
was found to significantly enhance susceptibility of the cells to
P. aeruginosa invasion (Fig. 4d). These results suggest that each of
these two factors, for whichmRNA levels were increased by tear fluid
pre-exposure, are directly involved in cellular resistance to
P. aeruginosa invasion.
Discussion
The data presented in this article show that tear fluid can induce
protective immunity in corneal epithelial cells against P. aeruginosa
invasion and cytotoxic virulence mechanisms. Tear fluid exposure
was found to change the expression of many genes, with the most
significant increased mRNA levels observed for RNase7 and ST2.
Accordingly, knockdown of either RNase7 or ST2 increased cellular
susceptibility to P. aeruginosa invasion, showing both factors play a
role in tear fluid-induced epithelial immunity to this pathogen.
RNase7 is a known antimicrobial (,14.5 kDa) with potent ribo-
nuclease activity first identified in human skin, found to play a
major role in determining the skin antimicrobial barrier16–18. It has
potent antimicrobial activity against various pathogens including
E. coli, Pseudomonas aeruginosa, Candida albicans, Staphylococcus
Figure 2 | Tears InduceAP-1 andNFkBActivation. a,Corneal epithelial cells were transfectedwithNFkB or AP-1 transcription factor-responsive firefly
luciferase and Renilla luciferase constructs, incubated with tears or cell culture media for 16 h then 3 h with P. aeruginosa antigens. Tears induced a
,25-fold increase in AP-1 activation, and,5-fold increase in NFkB; Fold increase 5 cells pre-exposed to tears with P. aeruginosa antigens over cells pre-
exposed to media with P. aeruginosa antigens b, Histatin-3 and hBD-3 mRNA induction in corneal epithelial cells exposed to tears for 6 h (relative to
media control); c, Induction of histatin-3mRNA in corneal cells pre-exposed to tears (16 h, washed, then inoculated with P. aeruginosa antigens for 3 h).
www.nature.com/scientificreports
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aureus and vancomycin resistant Enterococcus faecium16. RNase7 has
been shown to target the outer membrane protein I of Pseudomonas
aeruginosa19. In addition to its protective role in human skin, RNase7
expression was recently shown to be increased in human corneal
limbal epithelial cells stimulated with Acanthamoeba castellanii20.
ST2 is a member of the IL1R family and is found in either a soluble
(sST2) or transmembrane form (ST2L)21. Its established roles include
negative regulation of TLR signaling by sequestering recruitment of
adaptormolecules includingMyD88 and TIRAP, promotion of Th2-
type immune responses, and suppression of proinflammatory cyto-
kine production22, 23. Accordingly, ST2 has been shown to reduce
pathology during Leishmania major, Trichuris muris in the colon
and by respiratory syncytial virus in the lung24–26. Huang et al. have
also shown a role for ST2 and its ligand IL-33 in protecting against
pathology during P. aeruginosa keratitis, associated with altered
macrophage polarization, and reductions in bacterial load and proin-
flammatory responses27, 28. Results of the current study suggest a role
for ST2, in addition to modulating immune responses, which might
also explain its capacity to reduce pathology during infection; i.e.,
modulation of epithelial cell susceptibility to bacterial virulence fac-
tors. Given the complexity of already known effects of ST2, particu-
larly on TLR signaling23, 29, further studies will be needed to elucidate
exactly how ST2 protects cells against bacteria. However, possibilities
include that it impacts production of epithelial-expressed antimicro-
bials via its effects on TLR-mediating signaling or Th2 responses,
which each regulate expression of antimicrobial peptides30, 31.
Alternatively ST2 could impact, via effects on microbe recognition,
bacterial trafficking to intraepithelial perinuclear vacuoles that are
capable of killing intracellular bacteria32. Tear fluid was found to
prime cells for NFkB and AP-1 transcription factor activation, sup-
porting that downstream innate immune responses are impacted.
Recent studies have shown that the normal microbiota at some
mucosal surfaces can induce immunity in epithelial cells lining the
mucosa6, 33, 34 involving TLRs35 which detect microbe-associated
molecular patterns (MAMPs)36. DAMPs (damage associated
molecular patterns) can also trigger TLR receptor signaling and
therefore downstream effects37. Since the ocular surface lacks signifi-
cant microbiota, other mechanisms must be involved in maintaining
the normal immune tone of its surface epithelial cells during health.
Data presented in this report showing that tear fluid can modulate
epithelial immunity suggests the presence of TAMPs (tear associated
molecular patterns).Whether these act on the same receptors/signal-
ing pathways as other factors that modulate epithelial immunity, and
whether components of tears responsible are similar in structure to
MAMPs or PAMPs, remains to be determined.
While we have found changes to gene expression induced by tear
fluid, some involved in epithelial immunity to bacteria, it remains
possible that tear fluid influences cell immunity in other ways, for
example if tear components directly impact the surface biochemistry
of the epithelial cells, e.g. by binding directly to cells or by modifying
cellular factors directly. Further studies will be needed to address that
possibility.
The significance of these findings extends to the design of in vitro
cell culture studies. Standard methods for studying epithelial cell
biology, including cellular microbiology, involve growth of cells in
tissue culture media. The results of this study suggest that growth
media should be formulated to mimic the appropriate mucosal fluid
when studying mucosal epithelial cells in vitro.
Factors that stagnate mucosal fluids often cause susceptibility to
infection, such as cystic fibrosis, intubation, and contact lens wear.
While reduced clearance of microbes and/or biofilm formation very
likely contributes to susceptibility in these instances, the impact of
prolonged stagnation on mucosal fluid biochemistry and its sub-
sequent impact on epithelial immune tone, could be another topic
worthy of investigation.
In summary, the results of this study show that the role of mucosal
fluids in defense against infection stretches beyond effects on
microbe viability or virulence to actually enhancing cellular resist-
ance to microbes. These findings add to our understanding of how
mucosal surfaces resist infection during health, and suggest new
avenues for developing biocompatible agents to prevent, rather than
simply treat, pathology in susceptible patients.
Methods
Cell culture.Human telomerase-immortalized corneal epithelial cells (hTCEpi) were
maintained in 10 cm tissue culture treated Petri dishes (Becton Dickinson, Franklin
Lake, NJ) in serum-free KGM-2 medium (Lonza, Walkersville, MD) until confluent
as previously described38. Cells were then seeded onto 96-well tissue culture plate
(Becton Dickinson, Franklin Lake, NJ) and grown to ,80–90% confluence. 2 days
prior to experiment, the cells were incubated in high calcium KGM-2 medium
containing 1.15 mM Ca21 for 16 h, then washed with sterile phosphate-buffered
saline (PBS; Sigma, St. Louis, MO) before being incubated in either 40 ml of fresh
human tear fluid or high calcium KGM-2 without antibiotics either for 6 h or 16 h
depending on the experiment. All cells were incubated at 37uC with 5% CO2 while
culturing and during experiments.
Figure 3 | Microarray Analysis of Epithelial Cells Exposed to Tear and/or
P. aeruginosa antigens. a, b Heat-maps of differentially regulated probe
sets in epithelial cells incubated with human tear fluid for 6 h (a) or cells
pre-exposed to tear fluid for 16 h followed by 3 h incubation with
P. aeruginosa antigens (b). Red and green boxes indicate up- and down-
regulation, respectively, of probe sets with tear fluid.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 1 : 8 | DOI: 10.1038/srep00008 4
Preparation of bacteria. All bacteria were grown on trypticase soy agar plates
overnight at 37uC. Bacteria were suspended in basal KBM-2 media (without
antibiotics) to a spectrophotometer optical density of 0.1 at OD650 which is equivalent
to ,1 3 108 cfu/mL and diluted to ,1 3 106 cfu/mL for invasion and cytotoxicity
experiments. P. aeruginosa clinical isolates 6294 and 6206 were used for invasion and
cytotoxicity assays, respectively. Some experiments also involved the use of two
laboratory isolates of P. aeruginosa, strains PAO1 and 19960.
P. aeruginosa supernatant. P. aeruginosa strain PAO1 was grown as single colonies
on trypticase soy agar at 37 uC overnight. A single colony was then inoculated into
5 ml of trypticase soy broth and grown with aeration to late log phase (37 uC). The
culture broth was then centrifuged at 14,000 rpm (16,000 3 g) for 30 min and the
supernatant collected in a syringe, sterilized with a 0.22 mm polymer filter (Corning
Star Corporation, Cambridge, MA), aliquoted and stored at 280 uC until use in
experiments. Bacterial supernatant diluted 155 with basal KBM-2 media (without
antibiotics), or an equivalent amount of basal cell culture medium, was used to
stimulate corneal epithelial cells for experiments.
Invasion and cytotoxicity assays. Corneal epithelial cells were either pre-exposed to
high Ca21 media or human tear fluid for 16 h (for tear fluid pre-exposure
experiments), washed with 100 ml of pre-warmed PBS, then inoculated with 40 ml of
P. aeruginosa strain 6294 or strain 6206 diluted in basal KBM-2 media to a
concentration of ,1 3 106 CFU/ml. Triplicate wells were used for each sample.
Epithelial cells were incubated with bacteria for 3 h (37uC, 5.0 % CO2). The cells
were then washed with PBS and incubated with 100 ml of gentamicin solution
(0.4% [vol/vol]; 200 mg/ml; BioWhittaker, Walkersville, MD) in cell culture media.
After a 1 h incubation at 37uC, 100 ml of Trypan blue solution (10% [vol/vol]) in basal
KBM-2 media was added, and incubated for 15 min. The Trypan blue solution was
then replaced with 100 ml of basal KBM-2 media. Phase-contrast images were taken
on an inverted microscope (Olympus IX-70, Olympus America Inc., Center Valley,
PA) attached to a video camera (Optronics, Goleta, CA) at 2003 magnification.
Epithelial cells were considered vulnerable to bacterial cytotoxicity (i.e. dead/dying) if
they exhibited Trypan blue staining. Blue stained cells were also quantified for
statistical analysis. To quantify intracellular bacteria, epithelial cells were lysed in
Triton X-100 (0.25% [vol/vol]; LabChem Inc., Pittsburgh, PA) in PBS for 15 minutes.
The cells were then scraped for complete lysis and undiluted and 1021 dilutions plated
onto MacConkey agar plates to enumerate surviving (intracellular) bacteria by
viable count.
Bacterial growth assay. Bacterial growth and viability were tested by adding 50 ml of
bacteria suspended in either cell culture media, or tears with or without exposure to
corneal cells, to empty Eppendorf tubes. These suspensions were incubated at 37 uC
for 3 h and quantified by viable count. Initial suspensions were also quantified to
study bacteriostatic or bactericidal effects of tear fluid. These were done in triplicates.
Transfection and luciferase array assay. Human corneal epithelial cells were
reverse transfected using SureFECT (SABiosciences, Frederick, MD) onto Cancer
10-Pathway Reporter Array (SABiosciences, Frederick, MD). Each reporter consists
of a mixture of an inducible transcription factor responsive firefly luciferase reporter
and a constitutively expressing Renilla luciferase construct (2051). Firefly and Renilla
luciferase activities of cells incubated either inmedia or tear fluid for 16 h followed by
3 h incubation with P. aeruginosa supernatant were measured. The change in the
activity of each signaling pathway was calculated by comparing the normalized
luciferase activities of the reporter of each group.
RNA purification. Total RNA of corneal epithelial cells incubated in either cell
culturemedia or human tear fluid for 6 h and cells either pre-exposed tomedia or tear
fluid for 16 h followed by 3 h incubation with P. aeruginosa supernatant were
Figure 4 | RT-PCR Confirmation of Tear Induced Expression of RNase7 and ST2 and Their Protective Effect against P. aeruginosa Invasion. a, b, c,
Semi-quantitative RT-PCR confirmed that 6 h tear exposure alone or 16 h pre-exposure to tear fluid followed by 3 h incubation with P. aeruginosa
antigens induced RNase7 and ST2mRNA expression in corneal epithelial cells. d, siRNA knockdown of RNase7 or ST2 in corneal epithelial cells increased
P. aeruginosa invasion.
www.nature.com/scientificreports
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extracted with the RNeasy Kit (Qiagen, Valencia, CA) using Qiashredder columns for
cell lysis and inserting Qiagen on-column DNase steps to remove any contaminating
genomic DNA.
RNA target preparation/GeneChip microarray analysis. RNA quality was assessed
by using the Agilent Model 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).
Ten micrograms of total RNA was processed for use on the microarray by using the
Affymetrix GeneChip one-cycle target labeling kit (Affymetrix, Santa Clara, CA)
according to the manufacturer’s recommended protocols. The resultant biotinylated
cRNA was fragmented and then hybridized to the GeneChip Human Genome U133
Plus 2.0 Arrays (Affymetrix). The arrays were washed, stained, and scanned using the
AffymetrixModel 450 Fluidics Station andAffymetrixModel 3000 scanner, following
manufacturer’s recommended protocols, at the University of California Functional
Genomics Laboratory. Expression values were generated by using Microarray Suite
(MAS) v5.0 software (Affymetrix). Each sample and hybridization underwent a
quality control evaluation, including cRNA amplification of . 4-fold, percentage of
probe sets reliably detecting between 40% and 60% present call, and 39–59 ratio of
GAPDH gene.
Evaluation and normalization of affymetrix GeneChip data. The hybridizations
were normalized by using the RMA (robust multichip averaging) method from
Bioconductor to obtain summary expression values for each probe set. Gene
expression levels were analyzed on a logarithmic scale. The given background-
corrected and normalized log2 values were anti-logged and fold expression level
changes were determined by dividing the experimental group by the control. Any
gene showing differential expression by at least four fold and p 5 0.01 was subjected
to Affymetrix Annotation Files. Functional gene classifications were derived from
GeneOntology information found inNational Center for Biotechnology Information
(NCBI) database, Onto-tools (Intelligent Systems and Bioinformatics Laboratory
website, (http://vortex.cs.wayne.edu/Projects.html) and from independent literature
searches. The heat-map was generated using MeV.
Semi-quantitative RT-PCR. 1 mg of total purified RNA was converted to cDNA
using RETROscript Kit (Ambion, Austin, Texas). The expression of hBD-2, -3, LL-37,
histatin 3, ST2 and RNase7 mRNAs were assessed for each condition mentioned
previously using intron spanning primers. As an internal loading control, primers
specific for ß-actin was used. Polymerase chain reaction (PCR) products were
separated on 2 % agarose gel and visualized by ethidium bromide. Band intensities
were quantified using the FluorChem Q SA software (Alpha Innotech, Santa Clara,
CA) and normalized with those of ß-actin andmedium treated controls. Experiments
were repeated at least three times.
siRNA. HCECs were transfected with control siRNA (50 nmol/L), ST2 siRNA
(50 nmol/L), and RNase7 siRNA (50 nmol/L) by the use of Lipofectamine RNAi Max
(Invitrogen, Carlsbad, CA) for 6 hours. Cells were used for assays at 48 hours after
transfection. Expression levels of RNase7 and ST2 were determined by semi-
quantitative RT-PCR. Small interfering (si)RNAs were designed by Dharmacon Inc
(Lafayette, CO).
Statistical analysis. Data were expressed as mean 6 s. d (n 5 3 or 4 samples per
group) unless otherwise stated. Student’s t-test was used to evaluate the statistical
significance of differences between groups with P values , 0.05 considered
significant. All experiments were repeated at least three times.
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